Samir N. Khleif, MD
@samirnkhleif
Oncologist, Immuno-Oncology Scientist, Health Care Transformational Leader- Biomedical Scholar and professor Lombardi Cancer Center, Georgetown University
ID: 1655952998
http://sites.google.com/georgetown.edu/thekhleiflab/home 08-08-2013 18:27:36
970 Tweet
1,1K Followers
1,1K Following
Samir N. Khleif, MD from Georgetown University highlighting the importance of optimally priming T cells BEFORE PD-1 blockade. If the T cells are suboptimal primed, PD-1 blockade may actually induce T cell dysfunction #SITC21
Oops, forgot the tag! Samir N. Khleif, MD
Andy Weinberg giving a very informative talk on anti-OX40 an agent that has a biiig potential if used properly- should not be missed. Great scientist! Society for Immunotherapy of Cancer Earle A. Chiles Research Institute #SITC21 #sitc2021
Vijay Kuchroo discussed the latest in TIM3 targeting at the Immune Resistance Symposium. Great talk Society for Immunotherapy of Cancer Dana-Farber #SITC21 #sitc #SITC #sitc2021
At the Immune Resistance Symposium J Louise Lines discusses The role of VISTA in resistance Society for Immunotherapy of Cancer very informative! #SITC21 #sitc
Top Influencers of #sitc21: Society for Immunotherapy of Cancer Jennifer Guerriero, PhD Samir N. Khleif, MD Earle A. Chiles Research Institute Brendan Horton Dr. Elizabeth Jaffee More 📊 hcsm.io/2ULP6UF
John Wherry UPenn Medical Ethics & Health Policy describes new understanding of T cell exhaustion biology and anti-PD1 therapy - great insight Society for Immunotherapy of Cancer #SITC21 #SITC #sitc
Amazing talk from Ben Youngblood City of Hope about redesigning CAR-T strategy taking advantage of inhibiting exhaustion - part of the Immune Resistance Symposium Society for Immunotherapy of Cancer #sitc #SITC21 #sitc2021
Unfortunately I have to present virtually but still with lot of excitement #SITC21 join us for a debate on novel trial design to replace 3+3 dose escalation design for #Immunotherapy trials Samir N. Khleif, MD Joshua Reuss
Dr Kald Abdalla presenting alternative strategies for combination therapy Bristol Myers Squibb great insight Society for Immunotherapy of Cancer #sitc #SITC2021 #SITC
Very sad 2 be virtual 4 Paolo A. Ascierto’s #melanoma bridge/will miss being in room 4 great debates! I will be online 4 all of it Paulos Lab Omid Hamid MD Samir N. Khleif, MD Jason Luke, MD, FACP, FASCO Mario Mandala Jerome Galon @mcquadeMDLAc Kunle Odunsi, MD Professor Georgina Long AO (Bluesky @gvlongphdmd) Nicola Normanno alfredo budillon
Fabulous mtg National Academies Addressing Resistance in the Development of Cancer Immune Modulator Therapeutics: A Workshop. Tx Samir N. Khleif, MD @weinerg for organizing! It’s a 2 day meeting & link is live - join us! nationalacademies.org/event/11-14-20…
So good to be with good friends Elad Sharon & colleagues Jane Healy MD, National Academies for “Addressing Resistance to Immune Modulators in Cancer Workshop” thanks Samir N. Khleif, MD for the invite- hope we can contribute to accelerating IO drug development!
Hussein Tawbi, MD, PhD National Academies Samir N. Khleif, MD Amazing space National Academies and some incredibly talented, thoughtful, and dedicated researchers! Thanks so much to the organizers for including me!
Elad Sharon Hussein Tawbi, MD, PhD National Academies Samir N. Khleif, MD You stole my tweet, beautiful architecture was going to ask where… but you solved the mystery
Wanted to thank Samir N. Khleif, MD for co-organizing the workshop at National Academy of Sciences & taking the photo - the #AI+#LifeSciences at Institute for Experiential AI at Northeastern Northeastern U. Sam Scarpino nationalacademies.org/event/11-14-20…
Great to meet in person Samir N. Khleif, MD at the National Academy of Sciences - thanks for panel photo in the post: lnkd.in/gzyhrHgr - looking forward to workshop summary/recommendations, implications for #ai + #lifesciences at Institute for Experiential AI at Northeastern Northeastern U. - Sam Scarpino
GREAT DEBATE 1: Can computational biology improve clinical trial design? Dr Robert Beckman says NO! Dr. Samir N. Khleif, MD says YES! Both from Georgetown University #Bridge2022 Key word is Can! PROF KHLEIF WINS - 100% convinced Fondazione Melanoma Paolo A. Ascierto
michael briskin Chrystal Paulos 3PSolution Fondazione Melanoma Society for Immunotherapy of Cancer Done! Margarita Pizza x 3. One at its birthplace with guru and pizza aficionado Samir N. Khleif, MD.
